Concepts (56)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cell Transplantation | 5 | 2024 | 84 | 2.350 |
Why?
|
| Graft vs Host Disease | 3 | 2024 | 32 | 1.080 |
Why?
|
| Transplantation, Haploidentical | 1 | 2024 | 3 | 0.870 |
Why?
|
| Anemia, Sickle Cell | 1 | 2024 | 39 | 0.830 |
Why?
|
| Lymphocytes | 1 | 2021 | 91 | 0.660 |
Why?
|
| Chondromatosis | 1 | 2020 | 3 | 0.640 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2020 | 4 | 0.640 |
Why?
|
| Skin | 1 | 2021 | 155 | 0.630 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2020 | 20 | 0.630 |
Why?
|
| Mastocytosis, Systemic | 1 | 2019 | 2 | 0.620 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 9 | 0.610 |
Why?
|
| Baculoviral IAP Repeat-Containing 3 Protein | 1 | 2019 | 4 | 0.600 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2019 | 4 | 0.600 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2020 | 44 | 0.600 |
Why?
|
| Eosinophilia | 1 | 2019 | 8 | 0.600 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2019 | 10 | 0.600 |
Why?
|
| Imatinib Mesylate | 1 | 2019 | 15 | 0.590 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2019 | 25 | 0.590 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2019 | 18 | 0.590 |
Why?
|
| Sarcoma | 1 | 2019 | 29 | 0.590 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2019 | 31 | 0.580 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 472 | 0.480 |
Why?
|
| Child, Preschool | 3 | 2024 | 1207 | 0.400 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 686 | 0.400 |
Why?
|
| Transplantation, Homologous | 2 | 2021 | 48 | 0.320 |
Why?
|
| Transplantation Conditioning | 2 | 2024 | 13 | 0.260 |
Why?
|
| Child | 3 | 2024 | 2341 | 0.260 |
Why?
|
| Humans | 7 | 2024 | 29089 | 0.230 |
Why?
|
| Male | 4 | 2024 | 14056 | 0.220 |
Why?
|
| Adolescent | 2 | 2024 | 3239 | 0.210 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2021 | 7 | 0.180 |
Why?
|
| Th2 Cells | 1 | 2021 | 15 | 0.170 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 514 | 0.150 |
Why?
|
| SMARCB1 Protein | 1 | 2019 | 5 | 0.150 |
Why?
|
| Trisomy | 1 | 2019 | 19 | 0.150 |
Why?
|
| Cytokines | 1 | 2021 | 456 | 0.150 |
Why?
|
| Immunity, Innate | 1 | 2021 | 234 | 0.150 |
Why?
|
| Carcinogenesis | 1 | 2019 | 81 | 0.150 |
Why?
|
| Mice, Knockout | 1 | 2021 | 876 | 0.140 |
Why?
|
| Retrospective Studies | 1 | 2024 | 2651 | 0.130 |
Why?
|
| Prognosis | 1 | 2019 | 815 | 0.130 |
Why?
|
| Mutation | 1 | 2020 | 873 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 1672 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 433 | 0.120 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 415 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 490 | 0.120 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 1522 | 0.120 |
Why?
|
| Transcription Factors | 1 | 2019 | 524 | 0.120 |
Why?
|
| Female | 2 | 2024 | 15747 | 0.110 |
Why?
|
| Treatment Outcome | 1 | 2020 | 2430 | 0.100 |
Why?
|
| Young Adult | 1 | 2019 | 2856 | 0.090 |
Why?
|
| Mice | 1 | 2021 | 4846 | 0.090 |
Why?
|
| Animals | 1 | 2021 | 10758 | 0.060 |
Why?
|
| Abatacept | 1 | 2022 | 5 | 0.050 |
Why?
|
| Cyclophosphamide | 1 | 2022 | 43 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2022 | 151 | 0.040 |
Why?
|